Huntsworth’s (HNT) “Buy” Rating Reaffirmed at Peel Hunt
Separately, Berenberg Bank dropped their target price on Huntsworth from GBX 150 ($1.96) to GBX 140 ($1.83) and set a buy rating on the stock in a research report on Tuesday, November 27th.
Shares of LON HNT opened at GBX 85.60 ($1.12) on Wednesday. Huntsworth has a 1 year low of GBX 76.60 ($1.00) and a 1 year high of GBX 140 ($1.83). The stock has a market cap of $295.72 million and a PE ratio of 14.03. The company has a debt-to-equity ratio of 50.92, a quick ratio of 1.35 and a current ratio of 1.46.
Huntsworth plc, together with its subsidiaries, operates as a healthcare and communications company in the United Kingdom and rest of Europe, the United States, and internationally. The company operates through four divisions: Medical, Marketing, Immersive, and Communications. The Medical division provides scientific strategy and communications, publications planning and delivery, specialized medical writing, medical education, and payer and value communications services, as well as support services for internal medical teams.
Further Reading: Commodities
Receive News & Ratings for Huntsworth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsworth and related companies with MarketBeat.com's FREE daily email newsletter.